These life sciences jobs could triple. Inside the big effort to train workers.
Philadelphia cell and gene therapy, and gene editing companies are preparing to add more than 1,100 new employees per year for the next decade. The sector now employs about 4,900 workers in the region but that number is expected to grow to more than 11,274 jobs in just 10 years.
With such a clear sight on the projected growth and the workforce needs that the industry will have, the region is in an all-out race to grow a sustainable workforce… and the strategy is working.
Life Sciences Talent Pipeline Collaborative
Read the full article at: www.inquirer.com
Latest posts by Chris Frew (see all)
- Adaptive Phage Therapeutics Announces Strategic Agreement with ARLG to Support Phase 1b/2 Cystic Fibrosis Study - November 2, 2021
- Children’s National’s Dr. Kurt Newman Named WBJ’s 2021 CEO of the Year - October 26, 2021
- SciNeuro Pharmaceuticals and Mabylon AG to Collaborate on Development of Novel Therapeutics for Neurological Diseases | Business Wire - October 26, 2021
- Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company | Business Wire - October 21, 2021
- D&D Pharmatech Raises $51M in Series C Financing to Advance Phase 2 Clinical Trials for Neurodegenerative, Fibrotic, and Metabolic Diseases - October 19, 2021